|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 108, Issue 9 3059-3066, Copyright © 1995 by Company of Biologists
JOURNAL ARTICLES |
AL Jenkins, GL Howells, E Scott, BF Le Bonniec, MA Curtis and SR Stone
Department of Haematology, University of Cambridge, UK.
Human alpha-thrombin was a chemoattractant for human neutrophils yielding a maximal response of similar magnitude to that observed with formyl-Met-Leu-Phe. The observed chemotaxis was not due to stimulation of the proteolytically activated thrombin receptor since: (1) this receptor was not detected by flow cytometry; (2) the inactive thrombin mutant Ser195-->Ala elicited a chemotactic response indistinguishable from that caused by wild-type thrombin; (3) antibodies to the cleavage site of the proteolytically activated receptor did not affect thrombin-induced chemotaxis; (4) a thrombin receptor activating peptide (TRAP) failed to stimulate chemotaxis. These data indicate the existence of a thrombin receptor for neutrophil chemotaxis which is not activated by proteolysis. In addition, although wild-type and ser195-->Ala thrombin did not cause an increase in intracellular Ca2+, a Ca2+ response to TRAP was observed with neutrophils from some donors. The TRAP-induced increase in Ca2+ was reproducible, dose dependent and specific. The use of alanine-substituted peptides demonstrated that the Ca2+ response was due to TRAP stimulation of a receptor other than the proteolytically activated thrombin receptor. Thus, it is necessary to re-evaluate the assumption made in previous studies that responses to TRAP are mediated by the proteolytically activated thrombin receptor.
This article has been cited by other articles:
|
|
 |
|
  J. T. Ryaby, M. R. Sheller, B. P. Levine, D. G. Bramlet, A. L. Ladd, and D. H. Carney Thrombin Peptide TP508 Stimulates Cellular Events Leading to Angiogenesis, Revascularization, and Repair of Dermal and Musculoskeletal Tissues J. Bone Joint Surg. Am., November 1, 2006; 88(suppl_3): 132 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Song, C. N. Pagel, T. M. Campbell, R. N. Pike, and E. J. Mackie The Role of Protease-Activated Receptor-1 in Bone Healing Am. J. Pathol., March 1, 2005; 166(3): 857 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Yoshida, S. G. Elner, Z.-M. Bian, S. L. Kunkel, N. W. Lukacs, and V. M. Elner Thrombin Regulates Chemokine Induction during Human Retinal Pigment Epithelial Cell/Monocyte Interaction Am. J. Pathol., September 1, 2001; 159(3): 1171 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Macfarlane, M. J. Seatter, T. Kanke, G. D. Hunter, and R. Plevin Proteinase-Activated Receptors Pharmacol. Rev., June 1, 2001; 53(2): 245 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ross, B. Essary, B. A. de la Houssaye, Z. Pan, K. Mikule, O. Mubarak, and K. H. Pfenninger Thrombin Causes Pseudopod Detachment via a Pathway Involving Cytosolic Phospholipase A2 and 12/15- Lipoxygenase Products Cell Growth Differ., January 1, 2000; 11(1): 19 - 30. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Howells, M. Macey, C Chinni, L Hou, M. Fox, P Harriott, and S. Stone Proteinase-activated receptor-2: expression by human neutrophils J. Cell Sci., January 4, 1997; 110(7): 881 - 887. [Abstract] [PDF]
|
|
|
|
 |
|
 H. S. Suidan, S. P. Niclou, J. Dreessen, N. Beltraminelli, and D. Monard The Thrombin Receptor Is Present in Myoblasts and Its Expression Is Repressed upon Fusion J. Biol. Chem., November 15, 1996; 271(46): 29162 - 29169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
BrianD. Blackhart, K. Emilsson, D. Nguyen, W. Teng, ArnoldJ. Martelli, S. Nystedt, J. Sundelin, and RobertM. Scarborough Ligand Cross-reactivity within the Protease-activated Receptor Family J. Biol. Chem., July 12, 1996; 271(28): 16466 - 16471. [Abstract] [Full Text] [PDF]
|
|
